Quantcast

Latest gastroparesis Stories

2011-06-23 07:15:00

MILWAUKEE, June 23, 2011 /PRNewswire/ -- A bill to expand federal research of functional gastrointestinal (GI) and motility disorders, such as IBS, GERD and gastroparesis, has been introduced in the U.S. House of Representatives. The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011 (H.R. 2239) was introduced by original cosponsors Rep. James Sensenbrenner (R-WI-5) and Rep. Jim Moran (D-VA-8) on June 16. The proposed legislation was drafted by the...

2011-05-09 07:00:00

BOSTON, May 9, 2011 /PRNewswire/ -- Rhythm announced today results demonstrating that RM-131, the company's novel ghrelin agonist, was highly effective in restoring normal gastric function in animal models of delayed gastric emptying owing to a direct prokinetic effect. The results were the subject of an oral presentation by Lee M. Kaplan, MD, PhD (Massachusetts General Hospital, Harvard Medical School) titled "RM-131: A Potent Gastroprokinetic Agent" at the Digestive Disease Week 2011...

2010-04-05 09:09:15

People with severe stomach disorders can sometimes suffer from chronic vomiting. This symptom can be treated with electrical impulses from a pacemaker in the stomach. A new method enables patients who could benefit from this treatment to be identified, and electrical stimulation leads to reduced nausea and fewer days in hospital, shows a study from the Sahlgrenska Academy at the University of Gothenburg, Sweden. Gastric electrical stimulation has previously been shown to be effective in most...

2010-01-15 17:59:31

Diabetes mellitus is one of the most common chronic disease of the world and the prevalence of diabetes mellitus is over 10% in Taiwan. Gastroparesis is reported in 5% to 12% of diabetic patients. Superior mesenteric artery (SMA) syndrome is an uncommon disease resulting compression of the third portion of the duodenum from the superior mesenteric artery. However, SMA syndrome can cause the same symptoms as diabetic gastroparesis. A research team, led by Dr. Wen-Ming Wang from Kaohsiung...

2009-09-09 07:00:00

WILMINGTON, N.C., Sept. 9 /PRNewswire/ -- Wilmington Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV((TM)) ODT (metoclopramide HCl), an orally disintegrating formulation of metoclopramide for the treatment of gastroesophageal reflux disease (GERD) and diabetic gastroparesis. Wilmington has licensed METOZOLV ODT to Salix Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on gastrointestinal...

2009-06-02 08:24:26

Mayo Clinic researchers have shown that very low doses of inhaled carbon monoxide in diabetic mice reverses the condition known as gastroparesis or delayed stomach emptying, a common and painful complication for many diabetic patients. The findings will be presented on June 1 at Digestive Disease Week in Chicago. "This is a significant finding, as it shows that loss of the enzyme that makes carbon monoxide is the actor in this process and that it provides us with a clear approach toward a...

2009-06-02 08:04:30

Inhaling a dangerous gas could treat a common diabetic condition. Carbon monoxide inhalation can lead to brain damage or death. But in a recent study, researchers report inhaling very low doses of the gas reversed gastroparesis, delayed stomach emptying. The painful condition is a common complication for many diabetic patients, causing pain, nausea, vomiting, stomach spasms, weight loss and difficulty maintaining a proper blood glucose level. Diabetic mice with the gastric condition were...

2009-05-05 08:05:00

SAN DIEGO, May 5 /PRNewswire/ -- - Evoke Pharma, Inc., a privately-held specialty pharmaceutical company, announced today that it has initiated a Phase 2b clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis. Gastroparesis is a syndrome characterized by delayed emptying of the stomach into the intestine following a meal in the absence of mechanical obstruction. Diabetes is an important cause of gastroparesis, but other identified causes...

370572c9a414d9bd74461f1845d6423a1
2009-02-27 11:12:08

The US Food and Drug Administration is requiring makers of the heartburn drug Reglan to add a "black box" warning to inform patients that long term or high doses of the drug have been linked to involuntary movement throughout the body. More than 2 million Americans use the drugs to treat gastroesophageal reflux disease and other stomach problems, said the FDA. However, they warn that chronic use can cause tardive dyskinesia "“ characterized by uncontrollable repetitive movements of the...

2008-10-01 06:00:29

Tranzyme Pharma today announced positive Phase IIb results for its first-in-class, highly potent and selective ghrelin agonist, TZP-101, for the management of postoperative ileus (POI). Results demonstrated that TZP-101 was both safe and highly effective in reducing the duration of ileus following surgery in patients undergoing open bowel resection. Over 200 patients were enrolled in an adaptive, multinational, double-blind, placebo-controlled Phase IIb clinical trial designed to assess...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.